Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login
  • September 10, 2021
  • 2021 Abstracts

Adherence to intravitreal aflibercept therapy in patients with neovascular age-related macular degeneration: 4-month interim analysis of the ANDROMEDA study

Author: Focke Ziemssen (Germany)

Co-authors: Robert P. Finger, Albrecht Lommatzsch, Joachim Wachtlin, Ulrike Bauer-Steinhusen, Tobias Machewitz, Christine Rech

Purpose

There are gaps in understanding causes of non-adherence (NA) to anti-vascular endothelial growth factor (VEGF) therapy and subsequent undertreatment in patients with neovascular age-related macular degeneration (nAMD). The aim of the ANDROMEDA study is to assess treatment adherence over a period of 24 months during intravitreal aflibercept (IVT-AFL) therapy for nAMD, and to identify the impact of patient- and/or physician-related factors on adherence.

Setting/Venue

ANDROMEDA (NCT03714308) is a 24-month, prospective, observational cohort study in treatment-naïve as well as pre-treated patients with nAMD receiving IVT-AFL injections across 41 centers in Germany. All treatment decisions, including the decision to treat with IVT-AFL, were made by the treating physician.

Methods

A 4-month interim analysis was performed for the total study cohort as well as for treatment-naïve and pre-treated patients. The date of data cut-off for the 4-month analysis was May 31, 2021. Primary endpoints are the time to first occurrence of NA, defined as relevant deviation from on-label use of IVT-AFL, and reasons for missing a scheduled injection visit asked directly in telephone interviews. Secondary endpoints include best-corrected visual acuity (BCVA), health-related and vision-related quality of life, treatment satisfaction, and patient-reported barriers to adherence. Health-related and vision-related quality of life, treatment satisfaction, and treatment adherence barriers were assessed via telephone interviews using the 5-level EuroQol 5-Dimension (EQ-5D-5L) health questionnaire, the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25), the Macular Disease Treatment Satisfaction Questionnaire (MacTSQ), and the Patient Questionnaire for Longitudinal Assessment of Adherence Factors to Intravitreal (anti-vascular endothelial growth factor therapy) Therapy (LAF-IVT). Cox models were used to calculate hazard ratios (HR) and 95% confidence intervals (CI) for time to first occurrence of NA for defined baseline risk factors, which was visualized using Kaplan–Meier plots.

Results

Of a total of 554 patients enrolled in the study, 511 were valid for analysis of study endpoints. BCVA of naïve patients (58.6 ±18.55, n=224) was worse than that of pretreated patients (IVT-AFL pretreated 66.8 ±15.34, n=118; other pretreatment 64.8 ±15.78, n=169) and increased after 4 months to 63.3 ±17.47 in the naïve patient group and 66.8 ±15.34 and 64.8 ±15.78 in IVT-AFL pretreated and other pretreatment group respectively. Telephone interviews were documented for 91.2% of the total cohort at baseline and 89.2% at 4 months. The EQ-5D-5L and NEI-VFQ-25 scores were 0.8 (±0.20) and 79.2 (±13.32) at baseline and 0.8 (±0.23) and 79.7 (±13.72) at 4 months, respectively. The mean (± SD) MacTSQ (first applied at 4 months) score was 59.7 (±9.89). During the first 4 months, 45 (8.8%) patients reported missed injection visits in the LAF-IVT questionnaire. Patients reported "other diseases" as the most common reason (n=26, 57.8%) for a missed injection appointment during this observation period. The COVID-19 pandemic coincided to varying degrees with the enrolment and/or observation of 85% of the study population.

Conlusions

NAMD patients showed a high rate of non-adherence, even higher than anticipated before start of the study.Thus, not only the successful recruitment of comparable groups with and without IVT-AFL pretreatment promises insights into which phenomena are actually vs. patient perceived to be relevant for off-label treatment intervals. Pertinent risk factors will be identified in the analysis of the 12- and 24-month data and furthermore the impact of the COVID-19 pandemic on treatment adherence will be considered.

Financial Disclosure

F Ziemssen: Consulting: Allergan/Abbvie, Alimera, Bayer Healthcare, Boehringer-Ingelheim, Roche/Genentech, Novartis, NovoNordisk, MSD, Oxurion, Lecture fees: Allergan/Abbvie, Bayer Healthcare, CME Heallth, Novartis, ODOS, Roche R. Finger: Consulting: Bayer, Novartis, Roche/Genentech, Zeiss Meditech, Inositec, ProQR, Opthea, Alimera, Allergan; Funding: Novartis, Bayer, CentreVue, Zeiss Meditech, Heidelberg Engineering, Biogen, Alimera A. Lommatzsch: Lecture fees: Novartis, Bayer Vital GmbH, Pharm Allergan, Zeiss; Consulting: Novartis, Bayer Vital GmbH, C. Rech: Emplyee of Bayer Vital GmbH, T. Machewitz: Employee of Bayer Vital GmbH, U. Bauer-Steinhusen: employee Bayer Vital GmbH F.G.Holz: Consultating and funding: Genentech/Roche, Bayer, Boehringer-Ingelheim, Novartis, Allergan, Heidelberg Engineering, Kanghong; Consulting: Apellis, LIN Bioscience; Funding: Nightstar, Centervue, Optos, Acucela, Alcon; Advisory Boards: Acucela, Allergan, Avalanche, Bayer, Genentech, Heidelberg Engineering, Johnson & Johnson, LinBioscience, Novartis, Ophthotech, Roche, Oxurion.

Comments

Additional Co-author: 7. Christine Rech - employee Bayer Vital GmbH 8. Frank G. Holz: Department of Ophthalmology, University of Bonn, Germany
PrevPrevious
NextNext
Euretina Logo, Links to homepage.

European Society of Retina Specialists c/o Congrex Switzerland
Reinacherstrasse 131
4053 Basel
Switzerland

T +41 61 686 77 91
F +41 61 686 77 88

General Enquires: [email protected]

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Euretina 2026 Vienna

Ophthalmologica

Forum

Opportunities

Memberships

About

Code of Conduct

Privacy Policy

Contact Us

Newsletter Sign up

By clicking 'Subscribe', you agree to the terms of our Privacy Policy. 
 
 

Follow us

© EURETINA 2026 All rights reserved

  • Events
    • Euretina 2027 Copenhagen
      • Session Submission Terms
    • EuretinaAI: AI in Retina
    • Special Focus Meeting 2027 – Inherited Retinal Diseases
      • Registration
      • Poster Submission
      • Programme
    • Euretina 2026 Vienna
      • On-Demand
      • Congress Daily
      • Welcome
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
        • Wet Labs
        • WSPOS X EURETINA Paediatric Retina Day
        • World Retina @ Euretina
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Abstract Submission
      • Session Submission
      • Euretina Innovation Spotlight (EIS) 2026
      • General Information
        • FAQs
        • Euretina Run
        • Delegate Party
        • Sustainability Plan
        • Meeting Policy
        • Travel Details
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2026 – AI in Retina
      • Registration
      • Post-Event Hub
      • Hotels
      • Programme
      • Keynote
      • Poster Submission
    • Euretina 2025 Paris
      • 2025 Paris On Demand
      • Welcome
      • Congress Daily & Photo Gallery
      • Registration
      • Hotels
      • Programme
        • Keynote Lectures
      • Abstracts
      • Satellite Symposia
      • Abstract Submission
      • Late Breaking Submissions
      • EuroVeRsion Case Contest
      • Exhibitors & Sponsors
      • Euretina Innovation Spotlight (EIS)
      • General Information
        • Sustainability Plan
        • Travel Details
        • Delegate Party
        • Women in Retina Networking Breakfast
        • Press Details
        • Social Media Toolkit
    • Special Focus Meeting 2025 – Ocular Endotamponades
      • About
      • Programme
      • Poster & Video Presentations
    • Future Meetings
    • Upcoming Digital Events
  • Free Resources
    • Webinars
    • Podcasts
    • Case Club Cases
    • Euretina Guidelines
    • Euretina Brief
    • IME ePlatform
  • Membership
  • About
    • Euretina Board
    • Committees
    • Subspecialty Sections
    • Code of Conduct
    • Bye-laws
    • Our Sustainability Commitment
    • 25th Anniversary
      • Euretina Congresses 2001-2025
      • A History of Euretina
  • Opportunities
    • Observership Grant Programme – OPEN
    • RMCR Award Programme – OPEN
    • Mentorship Programme
      • Mentorship Alumni
    • Ramin Tadayoni Award
    • Jacqueline Cigrang AMD Research Grant
    • EBO-Euretina Exam
    • YOURS
      • Ophthalmologica Lecturer Proposal
    • Women in Retina
      • Overview
      • Women in Retina Committee
      • Women in Retina Survey 2026
      • Women in Retina Networking Breakfast 2026
      • Women in Retina Networking Breakfast 2025
      • Interview with Anat Loewenstein
      • Women in Retina Interviews 2025
      • Women in Retina Interviews 2023
      • Euretina White Paper on Gender Diversity
      • Euretina Survey on Gender Diversity
    • BEAVRS VR Database
    • CME Credits
  • Member Login